Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · March 21, 2022

Eluxadoline for Treatment of Patients With IBS-Diarrhea With or Without Bile Acid Diarrhea

Digestive Diseases and Sciences


Additional Info

Disclosure statements are available on the authors' profiles:

Digestive Diseases and Sciences
Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study
Dig. Dis. Sci. 2022 Feb 05;[EPub Ahead of Print], P Vijayvargiya, M Breen-Lyles, SL Nord, D Maselli, I Busciglio, R Boinpally, A Muslin, TJ Carrothers, M Camilleri

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading